NDC 47335-0382-81
Duloxetine 30 mg/1 CAPSULE, DELAYED RELEASE
Available — 2-Day Shipping
NDC
47335-0382-81
Generic Name
Duloxetine
Brand Name
Duloxetine
Strength
30 mg/1
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Package Size
—
Labeler
Sun Pharmaceutical Industries, Inc.
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Duloxetine delayed-release capsules USP are indicated for the treatment of: • Major depressive disorder in adults • Generalized anxiety disorder in adults and pediatric patients 7 years of age and older • Diabetic peripheral neuropathic pain in adults • Fibromyalgia in adults • Chronic musculoskeletal pain in adults Additional pediatric use information is approved for Eli Lilly and Company, Inc.’s CYMBALTA (duloxetine) delayed-release capsules. However, due to Eli Lilly a…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All Duloxetine Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other Duloxetine NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 47335-0382-81 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).